(Reuters) - Sanofi's second-quarter profit rose 3.2% on strong demand for its blockbuster asthma drug Dupixent and better-than-expected sales of new launches, with the company now expecting a stable full-year profit compared to a prior forecast of a fall. Operating income, excluding one-off items, rose 3.2% to 2.81 billion euros ($3.05 billion), above the 2.08 billion euros expected on average...

July 25 (Reuters) - Anglo-Swedish drugmaker AstraZeneca ( AZN ) on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases. ...

TOKYO (Reuters) -Japan's Nissan Motor ( NSANF ) slashed its annual outlook after posting a 99% decline in first-quarter operating profit due to weak U.S. sales performance on Thursday, sending its shares sharply lower. Operating profit for the April-June period totalled 995 million yen ($6.51 million), compared with 128.6 billion yen in the same period a year earlier, far short...

SYDNEY (Reuters) - An Australian judge said on Thursday it was not proven that an ingredient in Bayer's Roundup weedkiller increases the risk of cancer in users. ...